User profiles for Amey S. Dhopeshwarkar

amey dhopeshwarkar

Assistant Scientist
Verified email at indiana.edu
Cited by 819

Slowly signaling G protein–biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine …

X Lin, AS Dhopeshwarkar, M Huibregtse, K Mackie… - Molecular …, 2018 - ASPET
The CB 2 cannabinoid agonist LY2828360 lacked both toxicity and efficacy in a clinical trial
for osteoarthritis. Whether LY2828360 suppresses neuropathic pain has not been reported, …

Cannabinoid CB2 agonist AM1710 differentially suppresses distinct pathological pain states and attenuates morphine tolerance and withdrawal

AL Li, X Lin, AS Dhopeshwarkar, AC Thomaz… - Molecular …, 2019 - ASPET
AM1710 (3-(1,1-dimethyl-heptyl)-1-hydroxy-9-methoxy-benzo(c) chromen-6-one), a
cannabilactone cannabinoid receptor 2 (CB2) agonist, suppresses chemotherapy-induced …

The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: inhibition by phthalate esters in vitro

KM Bisset, AS Dhopeshwarkar, C Liao… - Neurochemistry …, 2011 - Elsevier
This research examines the in vitro interaction of phthalate diesters and monoesters with the
G protein-coupled cannabinoid 1 (CB 1 ) receptor, a presynaptic complex involved in the …

The actions of benzophenanthridine alkaloids, piperonyl butoxide and (S)-methoprene at the G-protein coupled cannabinoid CB1 receptor in vitro

AS Dhopeshwarkar, S Jain, C Liao, SK Ghose… - European journal of …, 2011 - Elsevier
This investigation focused primarily on the interaction of two benzophenanthridine alkaloids
(chelerythrine and sanguinarine), piperonyl butoxide and (S)-methoprene with G-protein-…

Actions of benzophenanthridine alkaloids and various synthetic compounds on the cannabinoid-1 (CB1) receptor pathway of mouse brain with particular reference to …

AS Dhopeshwarkar - 2012 - summit.sfu.ca
Benzophenanthridine alkaloids chelerythrine and sanguinarine inhibited the binding of
3HCP55940 and 3HSR141716A to mouse brain membranes IC50s approx. 1-2 µM. Piperonyl …

Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with …

AS Dhopeshwarkar, RA Nicholson - European Journal of Pharmacology, 2014 - Elsevier
… After verifying the IC 50 s of sanguinarine, chelerythrine, piperonyl butoxide and (S)-methoprene
that we … AS Dhopeshwarkar conducted all experiments as part of his Ph.D. research. …

CB2 cannabinoid receptors as a therapeutic target—what does the future hold?

A Dhopeshwarkar, K Mackie - Molecular pharmacology, 2014 - ASPET
The past decades have seen an exponential rise in our understanding of the endocannabinoid
system, comprising CB 1 and CB 2 cannabinoid receptors, endogenous cannabinoids (…

Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway

A Dhopeshwarkar, K Mackie - Journal of pharmacology and experimental …, 2016 - ASPET
The CB2 cannabinoid receptor (CB 2 ) remains a tantalizing, but unrealized therapeutic target.
CB 2 receptor ligands belong to varied structural classes and display extreme functional …

Two Janus cannabinoids that are both CB2 agonists and CB1 antagonists

A Dhopeshwarkar, N Murataeva, A Makriyannis… - … of Pharmacology and …, 2017 - ASPET
The cannabinoid signaling system includes two G protein–coupled receptors, CB 1 and CB
2 . These receptors are widely distributed throughout the body and have each been …

Where's my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol

N Murataeva, A Dhopeshwarkar, D Yin… - Pharmacological …, 2016 - Elsevier
2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid in the brain
and an agonist at two cannabinoid receptors (CB 1 and CB 2 ). The synthesis, degradation …